DGIMed Ortho's bone implants get FDA clearance
This article was originally published in Clinica
DGIMed Ortho's drill and intramedullary nail system, for repairing fractures of long bones such as the femur and tibia, has received US FDA 510(k) clearance. These fractures are traditionally treated with rods that are inserted into the centre of a bone and locked in place with screws. However, this procedure requires X-rays to identify where the screws must be placed, and can take up to 45 minutes. DGIMed's product is a rod that releases markers from inside the bone, which indicate where the screws should enter. This can "significantly reduce" the time of surgical procedures, the Minnetonka, Minnesota firm claims.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.